Initial Dossier Route for Non-Sterile Imported Class IIa, IIb and III Devices

1. Key takeaways

For non-sterile imported devices classified as Class IIa, IIb or III, Egypt provides a channel distinct from the sterile route. Where the dossier is complete, the device follows the same procedure as Section 4.1 (workflow no.1). Where the dossier is incomplete, the company may submit only the initial registration dossier (workflow no.2): the initial dossier requires only the Declaration of Conformity, the CE certificate, ISO 13485:2016, together with a reference-country FSC for Class IIb and III devices and a country-of-origin FSC for Class IIa devices, and on that basis a provisional acceptance number is issued. With that number the company may first obtain import approval. Thereafter a completion period of 18 months is granted, of which the first 6 months are for submitting the main documents in accordance with Annex 1; once the final acceptance number is obtained, a further 1-year import grace period applies.

2. Legal basis

3. Expert insights

Insight one: this pathway is in essence an exchange of time for market access, and it is the one most used by manufacturers from the Chinese mainland.

Because the Chinese mainland is not on the list of reference countries, non-sterile Class IIb and III imported devices would ordinarily require a reference-country FSC, and obtaining such a certificate itself takes time. Section 4.2.1 allows the company to secure a provisional acceptance number and import approval on the strength of the initial dossier first, shifting the pressure of obtaining the reference-country FSC into the 18-month window that follows. (Practical estimate: the concrete acquisition plan must be designed in light of the product’s actual marketing status in the reference country concerned.)

Insight two: the FSC sourcing requirement differs between Class IIa and Classes IIb/III, and Class IIa carries explicit substitution and catch-up rules.

The initial dossier requires Class IIb and III devices to present a reference-country FSC, while Class IIa devices may present an FSC from the country of origin. Moreover, where a reference-country FSC cannot be obtained for Class IIa, the guide permits a non-reference-country FSC to be submitted first, provided that the reference-country FSC is supplied within the 6-month grace period. This is the only place in the guide where an explicit arrangement of first non-reference, then reference, is spelled out, and it materially changes the sequencing of certificate work for Class IIa products.

Insight three: a missing ISO 13485:2016 certificate does not cause rejection, but triggers a 6-month catch-up obligation.

The guide states expressly that where a device of any class lacks the ISO 13485:2016 certificate, the dossier may be provisionally accepted, subject to submission of the certificate within the 6-month grace period. This differs from the practice of many markets, where the absence of a quality management system certificate blocks acceptance altogether. It is a pragmatic Egyptian arrangement, but it converts a filing problem into a deadline-management problem, and the 6-month node must be tracked from the day of provisional acceptance.

Insight four: devices of the same group must be declared together is a hidden but high-risk constraint.

The guide provides that if any item on the invoice of an import approval application is found to form part of a non-sterile device group, then all items of that group must be submitted in the same initial registration dossier. This rule directly multiplies the documentation volume and the cycle time of a single project. When companies partition their filing units, they must first determine the group relationships of the invoice items, because a group discovered later will force a consolidated re-filing that undoes the original splitting strategy.

Insight five: a hard gate stands at the end of the grace periods.

The guide states that where the periods described above expire and the documents listed in Annex 1 have not been completed, no import approval will be granted any longer. On the other hand, for repeated imports of the same declared items, the company continues to use the same provisional acceptance number and need not re-substantiate the application before the registration department. The combination is thus firm on the documentary deadline but considerate on repeat transactions, which rewards companies that keep accurate internal records of their number usage.

4. Practical recommendations

1. Determine eligibility for the initial dossier channel first: non-sterile imported Class IIa, IIb and III devices with incomplete dossiers should take this pathway in preference.
2. Prepare FSCs from different sources by class: for Class IIb/III prepare the reference-country FSC directly; for Class IIa the country-of-origin FSC may be used, while the reference-country FSC effort is started in parallel.
3. Do not stall when ISO 13485:2016 is missing: provisional acceptance can be requested, but the 6-month catch-up node must be locked into the calendar.
4. Declare by group, not by item: determine first whether invoice items belong to the same non-sterile device group, so as to avoid a later demand for consolidated group filing.
5. Manage the 18 months in two segments: the main documents go in during the first 6 months to secure the final acceptance number, after which the 1-year import grace period begins.
6. Reuse the same provisional acceptance number for repeat imports: maintain an internal ledger so that repeated substantiation before the registration department is avoided.

5. Verification checklist

• □ The product is a non-sterile imported device classified as IIa, IIb or III
• □ The four documents of the initial dossier are in place: DoC, CE, ISO 13485:2016 and FSC
• □ The FSC source matches the class (IIb/III reference country; IIa country of origin plus reference-country FSC within 6 months)
• □ It has been determined whether invoice items belong to the same device group, and same-group items have been filed together
• □ The 18-month completion period and the first-6-month main-document node have been scheduled
• □ The 1-year import grace period after the final acceptance number has been built into the sales plan
• □ A ledger for reuse of the same provisional acceptance number on repeat imports has been established

Legal information verified as of 29 October 2026. The non-sterile imported pathway described in this article follows the current text of Section 4.2.1 of EDREX: GL.CAMD.002 Version 2; where the guide is revised, the positions must be re-checked.

• Egypt local resources: GRZAN assists manufacturers from the Chinese mainland and overseas with medical device registration, import approval and change applications before the Egyptian Drug Authority (EDA), including design of the registration applicant arrangement (importing company, local factory or scientific office), preparation for scientific committee assessment, argumentation of routes for obtaining free sale certificates from reference countries, Arabic localization of labels and instructions for use, and the establishment of vigilance systems and periodic reporting.
• Service capabilities: product attribute determination and risk classification (devices Class I–III / IVD Class A–D), registration and re-registration, applicability determination for system registration and bundled registration, three-category determination of changes, import approval and annual import plans, and support for vigilance reports and field safety corrective actions.
• Contact: hito.lin@grzan.cn; website www.grzan.cn.